PARK AVENUE SECURITIES LLC - ALLIANCEBERNSTEIN GBL HGH IN ownership

ALLIANCEBERNSTEIN GBL HGH IN's ticker is AWF and the CUSIP is 01879R106. A total of 127 filers reported holding ALLIANCEBERNSTEIN GBL HGH IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PARK AVENUE SECURITIES LLC ownership history of ALLIANCEBERNSTEIN GBL HGH IN
ValueSharesWeighting
Q4 2022$1,111,000
-99.9%
120,542
-1.3%
0.02%
-9.1%
Q3 2022$1,085,000,000
+92397.9%
122,188
+1.8%
0.02%
-4.3%
Q2 2022$1,173,000
-7.7%
120,055
+5.6%
0.02%
+4.5%
Q1 2022$1,271,000
-99.9%
113,694
+8.6%
0.02%0.0%
Q4 2021$1,270,000,000
+108354.3%
104,710
+9.7%
0.02%
-8.3%
Q3 2021$1,171,000
+4.5%
95,476
+6.6%
0.02%0.0%
Q2 2021$1,121,000
+12.9%
89,588
+6.9%
0.02%0.0%
Q1 2021$993,000
+4.4%
83,804
+3.7%
0.02%
-7.7%
Q4 2020$951,000
+23.5%
80,806
+10.3%
0.03%0.0%
Q3 2020$770,000
+14.4%
73,243
+10.0%
0.03%
+4.0%
Q2 2020$673,000
+35.1%
66,586
+23.7%
0.02%
-40.5%
Q1 2020$498,000
+14.5%
53,815
+49.9%
0.04%
+133.3%
Q4 2019$435,000
+27.6%
35,902
+26.3%
0.02%
+12.5%
Q3 2019$341,000
+23.1%
28,436
+21.0%
0.02%
-48.4%
Q2 2019$277,000
+14.0%
23,504
+12.9%
0.03%
+138.5%
Q1 2019$243,000
+5.2%
20,812
-0.4%
0.01%
-62.9%
Q4 2018$231,000
-1.7%
20,894
+3.9%
0.04%
-7.9%
Q3 2018$235,000
+15.8%
20,115
+13.7%
0.04%
+5.6%
Q2 2018$203,000
+29.3%
17,688
+34.1%
0.04%
+2.9%
Q1 2018$157,00013,1940.04%
Other shareholders
ALLIANCEBERNSTEIN GBL HGH IN shareholders Q1 2022
NameSharesValueWeighting ↓
McGowan Group Asset Management, Inc. 4,434,108$43,010,8506.79%
Sowa Financial Group, Inc. 541,653$5,2543.94%
KENNEDY INVESTMENT GROUP 278,074$2,697,3161.62%
Uncommon Cents Investing LLC 268,210$2,601,6370.95%
Independent Wealth Network Inc. 108,750$1,054,8800.65%
Quad-Cities Investment Group, LLC 93,082$902,8930.61%
SMH CAPITAL ADVISORS INC 26,121$253,0000.59%
Vanguard Capital Wealth Advisors 37,000$358,9000.33%
FOUNDERS FINANCIAL SECURITIES LLC 145,075$1,407,2240.18%
SFI Advisors, LLC 18,827$182,6220.18%
View complete list of ALLIANCEBERNSTEIN GBL HGH IN shareholders